Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

In Year Made Unusual By COVID-19, Still More Unusual Consumer Health Claims Surface In US

Dec 22 2020

• By Malcolm Spicer

Related Content

Like Kentucky’s Senior Senator, Paul Hoists Legislative Flag For US Hemp Industry Growth

Dec 21 2020

US Bill For CBD Supplement Path Draws Mixed Industry Response

Sep 12 2020

Unpublished And Under Review? US FDA’s CBD Policy Draft Guidance Still Has Industry Talking

Aug 04 2020

Additional Topics

International United States US States Coronavirus COVID-19 Cannabidiol CBD Advertising, Marketing & Sales Commercial Companies Compliance Dietary Supplements Distribution E-Commerce Enforcement FDA Ingredients Manufacturing OTC Drugs Policy Regulation Recalls Consumer

More from Cannabis/CBD

More from Ingredients & Safety

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window